<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="joa370089" xml:lang="en" article-type="brief-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Arrhythm</journal-id><journal-id journal-id-type="iso-abbrev">J Arrhythm</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1883-2148</journal-id><journal-id journal-id-type="publisher-id">JOA3</journal-id><journal-title-group><journal-title>Journal of Arrhythmia</journal-title></journal-title-group><issn pub-type="ppub">1880-4276</issn><issn pub-type="epub">1883-2148</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40357354</article-id><article-id pub-id-type="pmc">PMC12067053</article-id>
<article-id pub-id-type="doi">10.1002/joa3.70089</article-id><article-id pub-id-type="publisher-id">JOA370089</article-id><article-id pub-id-type="other">JOA-2025-0195.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Spotlight</subject></subj-group><subj-group subj-group-type="heading"><subject>Spotlight</subject></subj-group></article-categories><title-group><article-title>Stepwise <styled-content style="fixed-case" toggle="no">
<bold>MRI</bold>
</styled-content> mode activation in a patient with a non&#x02010;<styled-content style="fixed-case" toggle="no">
<bold>MRI</bold>
</styled-content>&#x02010;conditional <styled-content style="fixed-case" toggle="no">
<bold>VDD</bold>
</styled-content> lead</article-title><alt-title alt-title-type="left-running-head">Kanai et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="joa370089-cr-0001" contrib-type="author" corresp="yes"><name><surname>Kanai</surname><given-names>Risa</given-names></name><degrees>RN, CCDS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-6963-4594</contrib-id><xref rid="joa370089-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>ri_kanai@saitama-med.ac.jp</email></address></contrib><contrib id="joa370089-cr-0002" contrib-type="author"><name><surname>Terazaki</surname><given-names>Yoshitaka</given-names></name><degrees>RN, CCDS</degrees><xref rid="joa370089-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="joa370089-cr-0003" contrib-type="author"><name><surname>Mori</surname><given-names>Hitoshi</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1172-2995</contrib-id><xref rid="joa370089-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="joa370089-cr-0004" contrib-type="author"><name><surname>Ikeda</surname><given-names>Yoshifumi</given-names></name><degrees>MD, PhD</degrees><xref rid="joa370089-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="joa370089-cr-0005" contrib-type="author"><name><surname>Kato</surname><given-names>Ritsushi</given-names></name><degrees>MD, PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9989-8708</contrib-id><xref rid="joa370089-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="joa370089-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Outpatient Clinic of Cardiology</named-content>
<institution>Saitama Medical University, International Medical Center</institution>
<city>Saitama</city>
<country country="JP">Japan</country>
</aff><aff id="joa370089-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Cardiology</named-content>
<institution>Saitama Medical University, International Medical Center</institution>
<city>Saitama</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>
Risa Kanai, Department of Cardiology, Saitama Medical University, International Medical Center, 1397&#x02013;1 Yamane, Hidaka&#x02010;Shi, Saitama 350&#x02010;1298, Japan.<break/>
Email: <email>ri_kanai@saitama-med.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>41</volume><issue seq="484">3</issue><issue-id pub-id-type="doi">10.1002/joa3.v41.3</issue-id><elocation-id>e70089</elocation-id><history>
<date date-type="rev-recd"><day>21</day><month>4</month><year>2025</year></date>
<date date-type="received"><day>25</day><month>3</month><year>2025</year></date>
<date date-type="accepted"><day>01</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Japanese Heart Rhythm Society.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Journal of Arrhythmia</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JOA3-41-e70089.pdf"/><abstract abstract-type="graphical"><p>A Medtronic MRI&#x02010;conditional device connected to an MRI&#x02010;non&#x02010;conditional VDD lead, which required specific adjustments in MRI mode settings to enable safe imaging. Although switching to MRI mode from VDD mode or VVI mode was not possible, it became possible after switching to DDD mode.<boxed-text position="anchor" content-type="graphic" id="joa370089-blkfxd-0001"><graphic xlink:href="JOA3-41-e70089-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="joa370089-kwd-0001">CIED</kwd><kwd id="joa370089-kwd-0002">MRI</kwd><kwd id="joa370089-kwd-0003">pacemaker</kwd></kwd-group><counts><fig-count count="4"/><table-count count="0"/><page-count count="4"/><word-count count="1600"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:22.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="JOA370089-cit-2001">
<string-name>
<surname>Kanai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Terazaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mori</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>R</given-names>
</string-name>. <article-title>Stepwise <styled-content style="fixed-case" toggle="no">
<bold>MRI</bold>
</styled-content> mode activation in a patient with a non&#x02010;<styled-content style="fixed-case" toggle="no">
<bold>MRI</bold>
</styled-content>&#x02010;conditional <styled-content style="fixed-case" toggle="no">
<bold>VDD</bold>
</styled-content> lead</article-title>. <source>J Arrhythmia</source>. <year>2025</year>;<volume>41</volume>:<fpage>1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/joa3.70089</pub-id>
</mixed-citation>
</p></notes></front><body id="joa370089-body-0001"><p>In Japan, a revised joint statement by three academic societies<xref rid="joa370089-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> will take effect in January 2024, marking a significant change in MRI imaging protocols. Previously, MRI imaging was permitted only when MRI&#x02010;conditional leads were connected to MRI&#x02010;conditional devices with the same brand. The revision now allows imaging even when MRI&#x02010;conditional devices are connected to MRI&#x02010;conditional or non&#x02010;conditional leads with mixed brands. Here, we report a case involving a patient with an MRI&#x02010;conditional device connected to an MRI&#x02010;non&#x02010;conditional VDD lead, which required specific adjustments in MRI mode settings to enable safe imaging. This case highlights the importance of tailored device programming in such scenarios.</p><p>The patient is a woman in her 60s who underwent VDD pacemaker implantation at the age of 38 because of complete atrioventricular block. Subsequent replacement surgeries were performed at the ages of 46, 54, and 63&#x02009;years. Following the most recent procedure, routine pacemaker checks were conducted at a nearby medical facility, with no notable complications reported. The patient, who had early&#x02010;onset Alzheimer's disease, required magnetic resonance imaging to assess eligibility for lecanemab therapy. However, MRI imaging could not be performed at a nearby medical facility, leading to a referral from a distant institution. Upon arrival, the patient's electrocardiogram showed atrial sensing and ventricular pacing at a rate of approximately 50 beats per minute (Figure&#x000a0;<xref rid="joa370089-fig-0001" ref-type="fig">1</xref>). A pacemaker was implanted in the left anterior chest wall, with no abandoned leads present (Figure&#x000a0;<xref rid="joa370089-fig-0002" ref-type="fig">2</xref>). The device in use was the Medtronic Attesta&#x000ae; Series ATDRS1, paired with a Medtronic Cap Sure&#x000ae; VDD5032&#x02010;58 lead, which is classified as MRI&#x02010;non&#x02010;conditional.</p><fig position="float" fig-type="FIGURE" id="joa370089-fig-0001"><label>FIGURE 1</label><caption><p>ECG. An ECG showed atrial sensing and ventricular pacing at a rate of approximately 50 beats per minute.</p></caption><graphic xlink:href="JOA3-41-e70089-g004" position="anchor" id="jats-graphic-3"/></fig><fig position="float" fig-type="FIGURE" id="joa370089-fig-0002"><label>FIGURE 2</label><caption><p>Chest x&#x02010;ray. A VDD pacemaker was implanted in the left anterior chest wall, with no abandoned leads.</p></caption><graphic xlink:href="JOA3-41-e70089-g003" position="anchor" id="jats-graphic-5"/></fig><p>Device diagnostics revealed the following:
<list list-type="bullet" id="joa370089-list-0001"><list-item id="joa370089-li-0001"><p>Predicted battery longevity: 5&#x02013;7.5&#x02009;years</p></list-item><list-item id="joa370089-li-0002"><p>Battery voltage: 2.78&#x02009;V</p></list-item><list-item id="joa370089-li-0003"><p>Cell impedance: 358&#x02009;&#x003a9;</p></list-item><list-item id="joa370089-li-0004"><p>Ventricular lead impedance: 768&#x02009;&#x003a9;</p></list-item><list-item id="joa370089-li-0005"><p>Ventricular pacing threshold: 0.75&#x02009;V at 0.4&#x02009;ms</p></list-item><list-item id="joa370089-li-0006"><p>Ventricular signal amplitude: Not detectable</p></list-item><list-item id="joa370089-li-0007"><p>Atrial sensing amplitude: 0.7&#x02013;1.0mv</p></list-item></list>
</p><p>For Class II imaging in revised Japanese statement, determining whether MRI mode can be activated is a critical consideration. Initial attempts to activate the MRI mode resulted in a programmer pop&#x02010;up message stating: <italic toggle="yes">&#x0201c;MRI cannot be safely performed with this system. One or more lead impedances exceed the safety requirements or are unconfirmed.&#x0201d;</italic> Subsequently, the pacemaker mode was switched to VVI, and another attempt to enable MRI mode was made, but the situation remained unchanged. Following this, the device was reprogrammed to DDD mode, allowing measurement of atrial impedance (1168&#x02009;&#x003a9;). The mode was then changed to VOO, and another attempt to activate MRI mode was made, which proved successful (Figure&#x000a0;<xref rid="joa370089-fig-0003" ref-type="fig">3</xref>). This stepwise reprogramming strategy underscores the importance of individualized device management in addressing MRI safety concerns for patients with MRI&#x02010; non&#x02010;conditional leads, enabling the successful utilization of advanced imaging modalities.</p><fig position="float" fig-type="FIGURE" id="joa370089-fig-0003"><label>FIGURE 3</label><caption><p>Steps to enter MRI Mode. Although switching to MRI mode from VDD mode or VVI mode was not possible, it became possible after switching to DDD mode.</p></caption><graphic xlink:href="JOA3-41-e70089-g002" position="anchor" id="jats-graphic-7"/></fig><p>Eleven days later, during the scheduled MRI imaging, the MRI mode was successfully activated. Given that the pacing rhythm was 100% atrial sensing and ventricular pacing mode, imaging was conducted in VOO mode at 70&#x02009;bpm.</p><p>Post&#x02010;MRI device evaluation showed no complications, with the following parameters:
<list list-type="bullet" id="joa370089-list-0002"><list-item id="joa370089-li-0008"><p>Ventricular impedance: 722&#x02009;&#x003a9;</p></list-item><list-item id="joa370089-li-0009"><p>Ventricular pacing threshold: 0.5&#x02009;V at 0.4&#x02009;ms</p></list-item></list>
</p><p>The patient experienced no adverse events, and the MRI data were successfully delivered to the referring medical institution, enabling the initiation of lecanemab therapy.</p><sec sec-type="discussion" id="joa370089-sec-0002"><label>1</label><title>DISCUSSION</title><p>In Japan, MRI&#x02010;conditional cardiac implantable electronic devices (CIEDs) have been reimbursed by insurance since 2012, enabling safe MRI examinations in medical institutions that meet specific facility standards.<xref rid="joa370089-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> The safety of MRI conditional devices has been demonstrated in numerous studies. Overseas, many MRI scans have been safely performed even on non&#x02010;MRI&#x02010;conditional devices.<xref rid="joa370089-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="joa370089-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> These findings have been reflected in the publication of guidelines concerning MRI examinations for patients with CIEDs. Notably, the Heart Rhythm Society in the United States issued guidelines in 2017, followed by the European Society of Cardiology in 2021.<xref rid="joa370089-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="joa370089-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> These developments underscore the global effort to expand MRI accessibility for CIEDs patients while maintaining safety, emphasizing the importance of nuanced clinical approaches and evidence&#x02010;based practice in this evolving field. Reflecting that global perspective, a revised statement<xref rid="joa370089-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> from the Japanese Society of Radiology, the Japanese Society for Magnetic Resonance in Medicine, and the Japanese Heart Rhythm Society will take effect on January 12, 2024. This revision has introduced a unique situation in Japan, where MRI imaging is possible only if the MRI mode can be configured for MRI conditional CIEDs, even if the leads are MRI non&#x02010;conditional leads. These scenarios emphasize the need for meticulous programming and individualized device assessment to ensure both patient safety and the efficacy of MRI examinations in this evolving regulatory framework.</p><p>In this case, the pacemaker was a Medtronic Attesta&#x000ae; Series ATDRS1 device connected to an MRI&#x02010;non&#x02010;conditional ventricular lead (Medtronic 5032&#x02013;58). For MRI mode activation in Attesta&#x000ae; devices, two critical parameters must be verified: lead impedance and battery longevity. MRI mode activation is inhibited if any of the following conditions are met: (1) Impedance Issues: Lead impedance is below 200&#x02009;&#x003a9;, exceeds 3000&#x02009;&#x003a9;, or cannot be measured. (2) Battery Longevity: The device is at the Recommended Replacement Time (RRT), Elective Replacement Indicator (ERI), or End of Service (EOS) stage. These programmed restrictions ensure the safety of both the device and the patient during MRI imaging. The successful resolution of these challenges in this case required specific adjustments and careful monitoring of device parameters, demonstrating the importance of understanding these technical limitations in clinical practice. In this case, it was thought that measurement failure occurred because of VDD mode, as atrial leads are not measured during standard measurement. After switching to VVI mode, MRI mode could not be activated for the same reason. Therefore, the settings were changed to DDD, and after measuring the atrial lead impedance (which was within the acceptable range at 1168&#x02009;&#x003a9;), the conditions for activating MRI mode were met. With pacemakers from Boston Scientific, Abbott, and Biotronik, it is possible to switch directly from VDD mode to MRI mode, and it is presumed that the phenomenon observed in this case would not occur. The requirement that atrial lead impedance must not be measured in VDD mode, and that the value must also fall within the normal range in order to switch to MRI mode, applies only to Medtronic and MicroPort devices. Therefore, caution is necessary when dealing with this phenomenon in pacemakers from these two manufacturers. Additionally, since devices will continue to evolve, it is important to constantly update our knowledge and adapt our approach to each individual case accordingly. There are likely to be various opinions regarding the acceptable range of impedance values. According to the latest statements, MRI is considered contraindicated for damaged leads. If the values fall within the range specified by the manufacturer, switching to MRI mode is possible. At our institution, MRI can be performed if a sufficiently safe margin in the pacing threshold can be ensured. However, if the margin is insufficient, we assess the risk&#x02013;benefit balance and determine whether to proceed with MRI through a multidisciplinary conference.</p><p>In conclusion, this case highlights the importance of understanding and navigating device&#x02010;specific safety protocols to enable MRI examinations in complex clinical scenarios.</p></sec><sec sec-type="COI-statement" id="joa370089-sec-0003"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors report no conflicts of interest.</p></sec><sec id="joa370089-sec-0004"><title>CONSENT</title><p>Informed consents were obtained from the patients to publish the case report.</p></sec></body><back><ref-list content-type="cited-references" id="joa370089-bibl-0001"><title>REFERENCES</title><ref id="joa370089-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="joa370089-cit-0001">
<string-name>
<surname>Aoki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hirai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hiraki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Makabe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Kuroda</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Operational Guidelines for MRI Examination in Patients with Cardiac Implantable Devices: Joint Statement by Three Societies</article-title>. (in Japanese). Available from: <ext-link xlink:href="https://new.jhrs.or.jp/pdf/guideline/mri_kensashishin202401.pdf" ext-link-type="uri">https://new.jhrs.or.jp/pdf/guideline/mri_kensashishin202401.pdf</ext-link>
</mixed-citation></ref><ref id="joa370089-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="joa370089-cit-0002">
<string-name>
<surname>Bhuva</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Moralee</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Brunker</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lascelles</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cash</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>KP</given-names>
</string-name>, et&#x000a0;al. <article-title>Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices</article-title>. <source>Eur Heart J</source>. <year>2022</year>;<volume>43</volume>(<issue>26</issue>):<fpage>2469</fpage>&#x02013;<lpage>2478</lpage>.<pub-id pub-id-type="pmid">34435642</pub-id>
</mixed-citation></ref><ref id="joa370089-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="joa370089-cit-0003">
<string-name>
<surname>Shah</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Hirsh</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Warnock</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mollerus</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Magnetic resonance imaging safety in nonconditional pacemaker and defibrillator recipients: a meta&#x02010;analysis and systematic review</article-title>. <source>Heart Rhythm</source>. <year>2018</year>;<volume>15</volume>(<issue>7</issue>):<fpage>1001</fpage>&#x02013;<lpage>1008</lpage>.<pub-id pub-id-type="pmid">29458192</pub-id>
</mixed-citation></ref><ref id="joa370089-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="joa370089-cit-0004">
<string-name>
<surname>Indik</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Gimbel</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Alkmim&#x02010;Teixeira</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Birgersdotter&#x02010;Green</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>GD</given-names>
</string-name>, et&#x000a0;al. <article-title>2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices</article-title>. <source>Heart Rhythm</source>. <year>2017</year>;<volume>14</volume>(<issue>7</issue>):<fpage>e97</fpage>&#x02013;<lpage>e153</lpage>.<pub-id pub-id-type="pmid">28502708</pub-id>
</mixed-citation></ref><ref id="joa370089-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="joa370089-cit-0005">
<string-name>
<surname>Glikson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Kronborg</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Michowitz</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Auricchio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Barbash</surname>
<given-names>IM</given-names>
</string-name>, et&#x000a0;al. <article-title>ESC scientific document group. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy</article-title>. <source>Eur Heart J</source>. <year>2021</year>;<volume>42</volume>(<issue>35</issue>):<fpage>3427</fpage>&#x02013;<lpage>3520</lpage>.<pub-id pub-id-type="pmid">34455430</pub-id>
</mixed-citation></ref></ref-list></back></article>